Skip to main content
Fig. 6 | World Journal of Surgical Oncology

Fig. 6

From: Long non-coding RNA PART1 predicts a poor prognosis and promotes the malignant progression of pancreatic cancer by sponging miR-122

Fig. 6

miR-122 inhibition partially reverses the inhibitory phenotypes of PART1 knockdown on pancreatic cancer cells. a The expression of miR-122 in PANC-1 cells transfected with sh_PART1, together with miR-122 inhibitor or inhibitor control was determined by qRT-PCR. b The cell proliferation ability of AsPC-1 cells in sh_NC + inhibitor control, sh_PART1 + inhibitor control, and sh_PART1 + miR-122 inhibitor groups was determined by CCK-8 assay. c miR-122 inhibitor could partially abrogate the inhibitory effect of PART1 knockdown on cell invasion in AsPC-1 cells. d miR-122 inhibitor could partially reverse the increased cell apoptotic rate in AsPC-1 cells caused by inhibiting PART1. *P < 0.05 and **P < 0.01

Back to article page